Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global BCG Vaccine Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global BCG Vaccine Market Status and Forecast (2016-2027)
      • 1.3.2 Global BCG Vaccine Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global BCG Vaccine Supply by Company

    • 2.1 Global BCG Vaccine Sales Volume by Company
    • 2.2 Global BCG Vaccine Sales Value by Company
    • 2.3 Global BCG Vaccine Price by Company
    • 2.4 BCG Vaccine Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional BCG Vaccine Market Status by Category

    • 3.1 BCG Vaccine Category Introduction
      • 3.1.1 Immune BCG
      • 3.1.2 Therapy BCG
    • 3.2 Global BCG Vaccine Market by Category
      • 3.2.1 Global BCG Vaccine Sales Volume by Category (2016-2021)
      • 3.2.2 Global BCG Vaccine Sales Value by Category (2016-2021)
      • 3.2.3 Global BCG Vaccine Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional BCG Vaccine Market Status by End User/Segment

    • 4.1 BCG Vaccine Segment by End User/Segment
      • 4.1.1 Hospitals
      • 4.1.2 Clinics
      • 4.1.3 Others
    • 4.2 Global BCG Vaccine Market by End User/Segment
      • 4.2.1 Global BCG Vaccine Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global BCG Vaccine Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global BCG Vaccine Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global BCG Vaccine Market Status by Region

    • 5.1 Global BCG Vaccine Market by Region
      • 5.1.1 Global BCG Vaccine Sales Volume by Region
      • 5.1.2 Global BCG Vaccine Sales Value by Region
    • 5.2 North America BCG Vaccine Market Status
    • 5.3 Europe BCG Vaccine Market Status
    • 5.4 Asia Pacific BCG Vaccine Market Status
    • 5.5 Central & South America BCG Vaccine Market Status
    • 5.6 Middle East & Africa BCG Vaccine Market Status

    6 North America BCG Vaccine Market Status

    • 6.1 North America BCG Vaccine Market by Country
      • 6.1.1 North America BCG Vaccine Sales Volume by Country (2016-2021)
      • 6.1.2 North America BCG Vaccine Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe BCG Vaccine Market Status

    • 7.1 Europe BCG Vaccine Market by Country
      • 7.1.1 Europe BCG Vaccine Sales Volume by Country (2016-2021)
      • 7.1.2 Europe BCG Vaccine Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific BCG Vaccine Market Status

    • 8.1 Asia Pacific BCG Vaccine Market by Country
      • 8.1.1 Asia Pacific BCG Vaccine Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific BCG Vaccine Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America BCG Vaccine Market Status

    • 9.1 Central & South America BCG Vaccine Market by Country
      • 9.1.1 Central & South America BCG Vaccine Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America BCG Vaccine Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa BCG Vaccine Market Status

    • 10.1 Middle East & Africa BCG Vaccine Market by Country
      • 10.1.1 Middle East & Africa BCG Vaccine Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa BCG Vaccine Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 BCG Vaccine Distributors
    • 11.3 BCG Vaccine Buyers

    12 Global BCG Vaccine Market Forecast by Category and by End User/Segment

    • 12.1 Global BCG Vaccine Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global BCG Vaccine Forecast by Category
      • 12.2.1 Global BCG Vaccine Sales Volume Forecast by Category
      • 12.2.2 Global BCG Vaccine Sales Value Forecast by Category
      • 12.2.3 Global BCG Vaccine Price Forecast by Category
    • 12.3 Global BCG Vaccine Forecast by End User/Segment
      • 12.3.1 Global BCG Vaccine Sales Volume Forecast by End User/Segment
      • 12.3.2 Global BCG Vaccine Sales Value Forecast by End User/Segment
      • 12.3.3 Global BCG Vaccine Price Forecast by End User/Segment

    13 Global BCG Vaccine Market Forecast by Region/Country

    • 13.1 Global BCG Vaccine Market Forecast by Region (2022-2027)
      • 13.1.1 Global BCG Vaccine Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global BCG Vaccine Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Merck
      • 14.1.1 Company Information
      • 14.1.2 BCG Vaccine Product Introduction
      • 14.1.3 Merck BCG Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Sanofi Pasteur
      • 14.2.1 Company Information
      • 14.2.2 BCG Vaccine Product Introduction
      • 14.2.3 Sanofi Pasteur BCG Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Japan BCG Lab
      • 14.3.1 Company Information
      • 14.3.2 BCG Vaccine Product Introduction
      • 14.3.3 Japan BCG Lab BCG Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Serum Institute of India
      • 14.4.1 Company Information
      • 14.4.2 BCG Vaccine Product Introduction
      • 14.4.3 Serum Institute of India BCG Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Intervax
      • 14.5.1 Company Information
      • 14.5.2 BCG Vaccine Product Introduction
      • 14.5.3 Intervax BCG Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 GSBPL
      • 14.6.1 Company Information
      • 14.6.2 BCG Vaccine Product Introduction
      • 14.6.3 GSBPL BCG Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 China National Biotec
      • 14.7.1 Company Information
      • 14.7.2 BCG Vaccine Product Introduction
      • 14.7.3 China National Biotec BCG Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information

    ...

      15 Conclusion

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global BCG Vaccine market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global BCG Vaccine market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Immune BCG
      Therapy BCG

      Segmented by End User/Segment
      Hospitals
      Clinics
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Merck
      Sanofi Pasteur
      Japan BCG Lab
      Serum Institute of India
      Intervax
      GSBPL
      China National Biotec
      Buy now